Bellicum Pharmaceuticals Inc. diskutieren
Bellicum Pharmaceuticals Inc.
WKN: A2PZPL / Symbol: BLCM / Name: Bellicum Pharma / Aktie / Biotechnologie & medizinische Forschung / Small Cap /
0,064 €
-9,29 %
Buy Bellicum Pharmaceuticals Inc.
Buy closed
Buy beendet
Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for BLCM provided by MarketBeat
Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for BLCM provided by MarketBeat
Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for BLCM provided by MarketBeat
Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for BLCM provided by MarketBeat
Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for BLCM provided by MarketBeat
Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for BLCM provided by MarketBeat
Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for BLCM provided by MarketBeat
Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for BLCM provided by MarketBeat
Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for BLCM provided by MarketBeat
Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for BLCM provided by MarketBeat
Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for BLCM provided by MarketBeat
Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for BLCM provided by MarketBeat
Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for BLCM provided by MarketBeat
Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for BLCM provided by MarketBeat
Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for BLCM provided by MarketBeat
Neueste Beiträge
Piper_Sandler in Chewy Inc diskutieren